A non-peptide NK1 receptor agonist showing subpicomolar affinity.
3-Quinolinecarboxamides have been synthesized and evaluated for their binding to the human NK(1) receptor. Several secondary amide derivatives show NK(1) receptor affinity in the picomolar range. The most active compound, hydroxymethylcarboxamide 3h showing an IC(50) value in the subpicomolar range, behaved as an agonist of NK(1) receptor in endothelial cell proliferation, inositol phosphate turnover, and NO-mediated cyclic GMP accumulation, thus proving it to be the first non-peptide NK(1) receptor agonist showing very high potency.
Dipartimento Farmaco Chimico Tecnologico and European Research Centre for Drug Discovery and Development, Università degli Studi di Siena, Via A. Moro, 53100 Siena, Italy. cappelli@unisi.it
Andrea
A
Cappelli
Germano
G
Giuliani
Gal la
Gl
Pericot Mohr Gl
Andrea
A
Gallelli
Maurizio
M
Anzini
Salvatore
S
Vomero
Aroldo
A
Cupello
Simona
S
Scarrone
Mario
M
Matarrese
Rosa Maria
RM
Moresco
Ferruccio
F
Fazio
Federica
F
Finetti
Lucia
L
Morbidelli
Marina
M
Ziche
D000577:Amides / Q000138:chemical synthesis* / Q000737:chemistry / Q000494:pharmacology; D000818:Animals; D002417:Cattle; D002455:Cell Division / Q000187:drug effects; D006152:Cyclic GMP / Q000096:biosynthesis; D004730:Endothelium, Vascular / Q000166:cytology / Q000187:drug effects; D006801:Humans; D066298:In Vitro Techniques; D007295:Inositol Phosphates / Q000378:metabolism; D009569:Nitric Oxide / Q000378:metabolism; D011804:Quinolines / Q000138:chemical synthesis* / Q000737:chemistry / Q000494:pharmacology; D018040:Receptors, Neurokinin-1 / Q000819:agonists*; D013329:Structure-Activity Relationship
D000577:Amides; D007295:Inositol Phosphates; D011804:Quinolines; D018040:Receptors, Neurokinin-1; D009569:Nitric Oxide; D006152:Cyclic GMP